newsfilter
← Latest News
Business Wire·

Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress

Prioritization of mRNA therapeutics pipeline extends cash runway into 2028 ARCT-032 (CF) Phase 2 interim data from first two cohorts expected in mid-2025 ARCT-032 (CF) Phase 2 expected to complete enrollment by year